Overall rank by patents
#28,682
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Elekta Instrument AB
USPTO PatentsView assignee record - 9 granted patents across 3 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
9
Total patents granted
3
CPC technology areas
15.9
Avg claims per patent
-
5-year filing velocity
The verdict
Elekta holds 9 US patents across 3 technology areas, rank #28,682 of 50,000 tracked assignees.
- #28,682
- of 50,000 US assignees by volume
- Top 28%
- by Innovation Score (43.6/100)
- 15.9
- avg claims per patent
Portfolio overview
Elekta Instrument AB has been granted 9 US utility patents between 2020 and 2025, placing Elekta Instrument AB at rank #28,682 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.9 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Elekta Instrument AB is one of the more focused assignees in the PatentsView dataset. By volume, Elekta sits between Einride AB (9 patents, rank #28,678) and Ellergon Antriebstechnik Gesellschaft M.b.h. (9 patents, rank #28,686) - the closest US assignees by grant volume. The composite Innovation Score of 43.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Elekta Instrument AB's 15.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Elekta Instrument AB against peers pursuing similar technology classes.
Who files at Elekta's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Einride AB
Einride AB
9 patents
- Electrophotonic-ic
ElectroPhotonic-IC Inc.
9 patents
- Electrosea
ElectroSea, LLC
9 patents
- Electrolux Consum…
Electrolux Consumer Products, Inc.
9 patents
- Elektrofi
Elektrofi, Inc.
9 patents
- Eliaz Therapeutics
Eliaz Therapeutics, Inc.
9 patents
- Elijah Tooling
Elijah Tooling, Inc.
9 patents
- Ellergon Antriebs…
Ellergon Antriebstechnik Gesellschaft m.b.H.
9 patents
- Elekta Instrument… ◀
Elekta Instrument AB
9 patents
What this shows Elekta holds 9 patents at rank #28,682, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Elekta
By rank, the assignees closest to #28,682 in granted patent volume.
- Einride AB #28,678 · 9 patents
- Electrophotonic-ic Inc. #28,679 · 9 patents
- Electrosea, Llc #28,680 · 9 patents
- Electrolux Consumer Products, Inc. #28,681 · 9 patents
- Elektrofi, Inc. #28,683 · 9 patents
- Eliaz Therapeutics, Inc. #28,684 · 9 patents
- Elijah Tooling, Inc. #28,685 · 9 patents
- Ellergon Antriebstechnik Gesellschaft M.b.h. #28,686 · 9 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in Elekta's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- ZOLL Medical Corporation 556 in class
- Koniniklijke Philips N.v. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
Elekta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 28% higher than 72% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 11.1% |
| 2021 | 1 | 11.1% |
| 2022 | 4 | 44.4% |
| 2024 | 2 | 22.2% |
| 2025 | 1 | 11.1% |
Which technologies does Elekta Instrument AB patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Standard
Frequently Asked Questions
How many patents does Elekta Instrument AB hold?
Elekta Instrument AB holds 9 US granted patents filed between 2020 and 2025, spanning 3 technology areas.
What is Elekta Instrument AB's Innovation Score?
Elekta Instrument AB has an Innovation Score of 43.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Elekta Instrument AB focus on?
Elekta Instrument AB's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 6 patents. The company has filed patents in 3 CPC subclasses total.
Is Elekta Instrument AB's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Elekta Instrument AB.
What does claim depth mean for Elekta Instrument AB's patents?
Elekta Instrument AB's patents average 15.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Elekta Instrument AB patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Elekta's 9 grants land it in the top 28% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Elekta ranks #28,682 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.